The largest database of trusted experimental protocols
> Physiology > Organism Function > Lipolysis

Lipolysis

Lipolysis is the metabolic process of breaking down lipids, or fat molecules, into smaller components such as fatty acids and glycerol.
This process is crucial for energy production and the regulation of fat storage in the body.
Lipolysis occurs in various tissues, including adipose tissue, liver, and muscle, and is controlled by hormones and other signaling pathways.
Understanding the mechanisms and factors that influence lipolysis is an important area of research, as it has implications for the management of obesity, diabetes, and other metabolic disorders.
PubCompare.ai offers a powerful AI-driven platform to optimize and improve the reproducibility of lipolysis research, helping scientists effortlessly locate the best protocols and discover the most effective products to accelerate their studies and drive meaningful insights.

Most cited protocols related to «Lipolysis»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014
Adipocytes Biological Assay Glucose Lipolysis System, Endocrine

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014
Adipocytes Adrenergic Agents Cells Colforsin Glycerin Isoproterenol Lipolysis

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014
Buffers Cell Extracts Cell Nucleus Cells COS-7 Cells Cultured Cells Hydrolysis Lipolysis TG-1101 Tg hydrolase Tissues
Between 2002 and 2006, 421 families with at least two long-lived Caucasian siblings, 1671 of their offspring and 744 of the offspring’s partners were recruited in the Leiden Longevity Study, without any selection on health. Males had to be aged 89 years or above and females 91 years or above3 (link)12 (link). For the current study (Switchbox), between March 2012 and July 2013, 135 offspring and partners from the LLS were measured at the study centre of the Leiden University Medical Centre. Inclusion criteria included being middle-aged (55–77 years) and having a stable body mass index (BMI) between 19 kg/m2 and 33 kg/m2. Participants were excluded if their fasting plasma glucose was above 7 mmol/l, if they had any significant chronic, renal, hepatic or endocrine disease, or if they used any medication known to influence lipolysis, thyroid function, glucose metabolism, GH/IGF-1 secretion or any other hormonal axis. Moreover, participants were excluded if they had a recent trans meridian flight, smoking addiction, use of more than 20 units of alcohol per week and extreme diet therapies. Other exclusion criteria specific for the subgroup only, were difficulties to insert and maintain an intravenous catheter, anemia (hemoglobin < 7.1 mmol/l), and blood donation within the last two months. Based on information obtained via telephone questioning, controls with a nonagenarian parent who had one or more nonagenarian siblings were also excluded. All women in this study were postmenopausal. The Switchbox protocol was approved by the Medical Ethical Committee of the Leiden University Medical Centre and was performed according to the Helsinki declaration. All participants gave written informed consent for participation.
Of the 135 subjects included, we excluded from analysis 17 subjects due to incomplete indirect calorimetry data and 6 subjects due to incomplete core body temperature data (Supplementary Fig. 1). Thus, data from 112 subjects (61 offspring, 51 partners) were available for analysis (and are referred to as full study sample). Complete series of 24 -hour blood samples were obtained for a subgroup of 38 participants (20 offspring, 18 partners).
Full text: Click here
Publication 2015
Addictive Behavior Anemia BLOOD Blood Donation Body Temperature Calorimetry, Indirect Catheters Caucasoid Races Endocrine System Diseases Epistropheus Ethanol Females Glucose Hemoglobin IGF1 protein, human Index, Body Mass Kidney Lipolysis Males Meridians Metabolism Nonagenarians Parent Pharmaceutical Preparations Plasma secretion Sibling Therapy, Diet Thyroid Gland Woman
The sera were transported on dry ice to the Department of Occupational and Environmental Medicine in Lund, Sweden, where all analysis of CB-153 and p,p'-DDE were performed. The CB-153 and p,p'-DDE were extracted from serum by solid phase extraction using on-column degradation of the lipids and analysis by gas chromatography mass spectrometry as previously described [16 (link)]. The relative standard deviations, calculated from samples analyzed in duplicate at different days, was 18% at 0.1 ng/mL (n = 990), 10 % at 0.5 ng/mL (n = 990) and 10 % at 2 ng/mL (n = 990) for CB-153 and 11 % at 1 ng/mL (n = 1058), 8 % at 3 ng/mL (n = 1058) and 7 % at 8 ng/mL (n = 1058) for p,p'-DDE. The detection limits were 0.05 ng/mL for CB-153 and 0.1 ng/mL for p,p'-DDE. The analyses of CB-153 and p,p'-DDE were part of the Round Robin inter-comparison program (Prof. Hans Drexler, Institute and Out-Patient Clinic for Occupational, Social and Environmental Medicine, University of Erlangen-Nuremberg, Germany) with analysis results within the tolerance limits. An internal control at 0.4 ng/mL for CB-153 and 0.6 ng/mL for p,p'-DDE was included in all analyzed series. The samples were analyzed in duplicate and the samples were re-analyzed a third time if the difference between the two determinations were higher than 30 %. However, at concentrations below 0.2 ng/mL an absolute deviation of 0.1 ng/mL between the duplicate samples was allowed. After the third analysis the two determinations fulfilling the above criteria was chosen. If none of the determinations fulfilled the criteria the sample were analyzed a fourth time.
Full text: Click here
Publication 2005
CB-153 Dry Ice Gas Chromatography-Mass Spectrometry Immune Tolerance Lipolysis Outpatients Robins Serum Solid Phase Extraction

Most recents protocols related to «Lipolysis»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Bile Bos taurus Digestion Intestines Lipolysis MG 46 ML 23 Molar Nonesterified Fatty Acids Pancreas Pancreatin Pigs PRSS1 protein, human Stomach Stomach Contents Titrimetry
Holstein dairy cows (n = 63) without veterinary intervention were selected from a large cohort (Hangjiang Dairy Farm, Hangzhou, China) of 2000 dairy cows seven days prior to the expected calving date. All cows were raised and managed under the same conditions including diet, water, and environment. Blood samples were collected from the coccygeal vein of cows 7 days prior to expected calving date and 7 days after calving using EDTA vacutainers. Moreover, fecal samples were collected at seven days postpartum from the rectum of cows by using sterilized gloves before morning feeding, transferred into 50-mL sterile tubes, and snap-frozen in liquid nitrogen.
Cows with excessive lipolysis were identified based on the plasma concentration of NEFA on 7 days postpartum [5 (link)]. Briefly, cows with plasma NEFA concentrations > 750 μmol/L on day seven postpartum were defined as high/excessive lipolysis (HNF), whereas those with plasma NEFA concentrations < 600 μmol/L were defined as low/normal lipolysis (LNF). We selected 18 dairy cows (LNF, n = 9; HNF, n = 9) out of 63 cows based on plasma NEFA concentrations (power = 0.9) after controlling for parity, milk yield, and body condition score (BCS). Body condition scores were measured by two people using a 5-point scale (1 = thin, 5 = fat) method described by Edmonson et al. [38 (link)] at 3-time points (06:00, 14:00, 20:00).
Full text: Click here
Publication 2023
BLOOD Cattle Coccyx Dairy Cow Diet Edetic Acid Feces Freezing Human Body Lipolysis Milk, Cow's Nitrogen Nonesterified Fatty Acids Plasma Rectum Sterility, Reproductive Veins
The “AddModuleScore” function of the Seurat R package (v 4.0.3) was used to compute the signature score of the gene set including the bile acid receptors gene set in all immune cells, as well as the downregulated genes related to BA regulation, response to cytokine, response to virus, defense response, and type1 interferon related in monocytes. The impact of lipolysis status on signature scores of immune cells was analyzed using a Wilcoxon rank sum test in R (v 4.1.0). Additionally, the correlation analysis between these pathways in monocyte was based on these scores [57 (link)].
Full text: Click here
Publication 2023
Cells Cytokine Genes Interferons Lipolysis Monocytes NR1H4 protein, human Virus
DNA libraries were constructed using the TruSeq Nano DNA Library Preparation Kit-Set (#FC-121–4001, Illumina, USA) following the manufacturer’s instructions. Metagenome libraries were then sequenced on an Illumina NovaSeq 6000 platform with PE150 at LC-Bio Technology Co., Ltd. (Hangzhou, China). Sequencing adapters were removed from de-multiplexed raw sequences using cutadapt (v 1.9). Then, the low-quality reads (quality scores < 20), short reads (< 100 bp), and reads containing more than 5% “N” records were trimmed by using the sliding-window algorithm method in fqtrim (v 0.94) [34 (link)]. Quality filtered reads were first aligned to bovine genome (bosTau8 3.7, https://doi.org/10.18129/B9. bioc. BSgenome. Btaurus. UCSC. bosTau8) by using bowtie (v 2.2) to filter out host contaminations [43 (link)]. Then, the remaining reads were subjected to de novo assembly for each sample using IDBA-UD (v 1.1.1) [44 (link)] and used to assign microbial functions and taxonomy. MetaGeneMark (v 3.26) [45 (link)] was used to predict the coding regions (CDS) of the assembled contigs, and CDS sequences of all samples were clustered using CD-HIT (v 4.6.1) to obtain unigenes. DIAMOND (v 0.9.14) was used to perform a taxonomic assessment of the gut microbiota based on the RefSeq database [46 (link)]. Microbial taxa with a relative abundance > 0.01% in more than 50% of the samples were used for downstream analysis. The wilcx test was used to identify the differentially abundant species, and significances were declared at P < 0.05. An assignment of microbial functions was done using the Kyoto Encyclopedia of Genes and Genomes (KEGG). The abundance of KEGG pathways was normalized to transcripts per million (TPM) [47 (link)], and pathways with > 5 TPM in at least 50% of the samples were used for downstream analysis.
NetShift [48 (link)] was used to identify microbial species serving as “drivers” of the altered microbiomes during excessive lipolysis. Briefly, microbiomes from LNF and HNF cows were defined as the control and case, respectively. Then, the betweenness value, which quantifies the importance of each selected species was obtained by a Spearman’s rank correlation analysis in LNF and HNF cows. Next, the betweenness values of each species were input into the NetShift package to calculate neighbor shift (NESH) cores. Node sizes are proportional to their scaled NESH scores, and the node is colored red if its betweenness value increases from control to case.
Full text: Click here
Publication 2023
Cattle Diamond DNA Library Gastrointestinal Microbiome Genes Genome Lipolysis Metagenome Microbiome
3T3-L1 fibroblasts were maintained in growth medium (Dulbecco's Modified Eagle Medium (DMEM) 4.5 g/L glucose + 10% Calf Serum). At full confluence, cells were then switched to differentiation media supplemented with insulin (1 mM), Rosiglitazone (1 µM), 3-isobutyl-1-methylxanthine (IBMX; 500 µM), Dexamethasone (500 nM), and T3 (50 nM) for 2 d. On day 2, cells were switched to differentiation media with insulin (1 mM), Rosiglitazone (1 µM), 3-isobutyl-1-methylxanthine (IBMX; 500 µM), and T3 (50 nM) for 2 d. On day 4, cells were switched to differentiation media only. At day 8, cells were synchronized with 200 nM of Dexamethasone for 30 min, washed once with differentiation media, and then maintained in differentiation media (73 (link), 74 (link)). The end of the 30-min dexamethasone treatment was considered at Cell-Time (CT) 0. For samples collected at 36- and 48 h postsynchronization, the medium was changed at CT24. Cells were incubated with 1 uM of isoproterenol in differentiation medium for 2 h at 12-, 24-, 36-, and 48 h postsynchronization. Samples of RNA and protein were collected for qPCR and western blot analysis. Additionally, cells were treated with 1 uM isoproterenol in low-glucose DMEM (1 g/L) with 2% bovine serum albumin (BSA) for 1 h for lipolysis measurement. Following treatment, the medium was collected from the wells and assessed for glycerol content using a Free Glycerol Kit (Sigma Aldrich).
Publication 2023
1-Methyl-3-isobutylxanthine 3T3-L1 Cells Cells Dexamethasone Eagle Fibroblasts Glucose Glycerin Insulin Isoproterenol Lipolysis Proteins Rosiglitazone Serum Serum Albumin, Bovine Western Blot

Top products related to «Lipolysis»

Sourced in United States, Germany, Denmark, Japan, Spain, Holy See (Vatican City State)
The Free Glycerol Reagent is a laboratory product designed to measure the concentration of free glycerol in a sample. It provides a reliable and accurate method for determining the level of free glycerol, which is a useful metric in various applications.
Sourced in United States, Germany, Japan, United Kingdom, Sao Tome and Principe, Canada, France, Denmark, Italy, Sweden
Isoproterenol is a synthetic catecholamine used as a laboratory reagent. It acts as a non-selective beta-adrenergic agonist, stimulating both beta-1 and beta-2 adrenergic receptors. Isoproterenol is commonly used in research applications to study cardiovascular and respiratory function.
Sourced in United States
The Free Glycerol Determination Kit is a laboratory product designed to quantify the concentration of free glycerol in various samples. It provides a simple and efficient method for determining the amount of free glycerol present, without interpretation or extrapolation on intended use.
Sourced in United States
The Adipolysis Assay Kit is a laboratory tool designed to measure adipocyte lipolysis, a process in which stored fat (triglycerides) is broken down into free fatty acids and glycerol. The kit provides reagents and protocols to quantify the release of glycerol, which serves as an indicator of adipocyte lipolysis.
Sourced in United States, Germany, United Kingdom, China, Italy, Japan, France, Sao Tome and Principe, Canada, Macao, Spain, Switzerland, Australia, India, Israel, Belgium, Poland, Sweden, Denmark, Ireland, Hungary, Netherlands, Czechia, Brazil, Austria, Singapore, Portugal, Panama, Chile, Senegal, Morocco, Slovenia, New Zealand, Finland, Thailand, Uruguay, Argentina, Saudi Arabia, Romania, Greece, Mexico
Bovine serum albumin (BSA) is a common laboratory reagent derived from bovine blood plasma. It is a protein that serves as a stabilizer and blocking agent in various biochemical and immunological applications. BSA is widely used to maintain the activity and solubility of enzymes, proteins, and other biomolecules in experimental settings.
Sourced in United States, Germany, United Kingdom, Macao
Fatty acid-free bovine serum albumin (BSA) is a purified, sterile-filtered protein preparation derived from bovine serum. It is commonly used as a stabilizing agent and carrier protein in various biochemical and cell culture applications.
Sourced in United States, Japan, Germany
CL316,243 is a laboratory product manufactured by Merck Group. It is a chemical compound used for research and scientific experimentation purposes. The core function of CL316,243 is to serve as a research tool, with specific details on its intended use not provided.
Sourced in United States, Sweden
F6428 is a laboratory equipment product. It is a centrifuge that can be used for separating components of a liquid mixture based on their density and relative size.
Sourced in United States
The Free Glycerol Reagent kit is a laboratory product designed to quantitatively determine the free glycerol concentration in a sample. The kit includes the necessary reagents and instructions to perform this analysis.
Sourced in United States
The Glycerol Assay Kit is a laboratory tool used to quantify the concentration of glycerol in a sample. It provides a simple and accurate method to measure glycerol levels.

More about "Lipolysis"

Lipolysis is the fundamental metabolic process of breaking down lipids, fats, and triglycerides into their smaller components, such as fatty acids and glycerol.
This crucial process is essential for energy production and the regulation of fat storage within the body.
Lipolysis occurs in various tissues, including adipose (fat) tissue, liver, and muscle, and is controlled by hormones and other signaling pathways.
Understanding the mechanicsms and factors that influence lipolysis is a key area of research, as it holds implications for the management of metabolic disorders like obesity, diabetes, and other conditions.
To optimize and improve the reproducibility of lipolysis research, PubCompare.ai offers a powerful AI-driven platform that helps scientists effortlessly locate the best protocols and discover the most effective products to accelerate their studies and drive meaningful insights.
Lipolysis can be measured and analyzed using various techniques and assays, such as the Free Glycerol Reagent, Isoproterenol, Free Glycerol Determination Kit, Adipolysis Assay Kit, and Glycerol Assay Kit.
These tools provide valuable data on the breakdown of lipids, fatty acids, and glycerol, which are essential for understanding the dynamics of fat metabolism.
Additionally, the use of Bovine Serum Albumin (BSA) and Fatty Acid-free BSA can aid in the study of lipolysis by providing a controlled environment for experimentation.
Futhermore, compounds like CL316,243 and F6428 have been utilized in lipolysis research due to their ability to stimulate and modulate the lipolytic process.
By leveraging the insights and capabilities of PubCompare.ai, researchers can optimize their lipolysis studies, enhance reproducibility, and uncover impactful discoveries that advance our understanding of this critical metabolic pathway.